Xybion WEBINAR

Xybion-AI-Tech

Clinical Trial Risk Management in the Post-COVID-19, All-Digital World: Predictive Transformation in Quality, Compliance and Risk Management

Sponsored by Xybion

December
2

Wednesday, Dec. 2, 2020  |  1:30 p.m. - 2:30 p.m. EST
Location: Your office or conference room (no need to travel!)

 

Want to improve your clinical trial quality, compliance and risk management? Predictive technologies incorporating artificial intelligence (AI) and machine learning along with smart digital cloud platforms can provide valuable insights for better decision making.

With agencies adopting COVID-19 mitigation protocols such as clinical trial eSource and eAudit for GXP inspections, this free webinar is your opportunity to leverage such technologies and bring innovative products to market faster.

These digital tools capture the right data and enable clinical trial professionals to predict risks and prioritize actions to reduce the risks over time.

Use these tools to help start trials early by ensuring site operations are always ready through predictive compliance risk management implementation. You’ll identify and minimize risks in site nonconformance, vendor noncompliance and service deliveries. And you can use them to manage data integrity and understand related risks.

In this free webinar Pradip K. Banerjee, Ph.D., Xybion’s Chairman of the Board and Chief Executive Officer, and compliance and risk specialist Brian Friel and Bob Friedman, Chief Technologist will discuss and demonstrate predictive technologies using specific examples.

Webinar Takeaways:

  • Modern technologies and algorithms to strategize, plan and implement predictive risk management solutions to clinical research and support operations

  • Digital technologies to help identify, predict and manage risks of the entire clinical trials process

  • Various methods and algorithms used to predict risks

  • Real-time data monitoring and data integrity issues and solutions

  • Technologies that can help prioritize your actions to make operations more efficient

These technologies will help you innovate your clinical trials, enhance quality, compliance and risk management. Join us by registering today for this free webinar.

Who Will Benefit:

  • Research and development
  • Clinical research
  • Clinical operations
  • Site leaders
  • Risk management personnel
  • Clinical quality and compliance
  • Clinical vendor compliance
  • Third party audit
  • Internal audit and risk management
Meet Your Presenters:

Pradip-Banerjee-92x121

 

Pradip K. Banerjee, Ph.D.
Chairman of the Board and Chief Executive Officer
Xybion

Pradip K. Banerjee, Ph.D. is Xybion’s Chairman of the Board and Chief Executive Officer. He is the founding Managing Partner (retired) of Accenture’s research and development line of business. He is an entrepreneurial senior executive with more than 30 years of in-depth experience in the global life sciences, healthcare and services industries in operations, strategic management, business development, investments and new venture creations. Previously, he held several research and development management positions at Abbott, Glaxo-Smith Kline and also served as president and CEO of the Science Center in Philadelphia.

Brian-Friel-92x121

 

Brian Friel
Compliance and Risk Specialist
Xybion

Brian Friel, who has more than 20 years of experience in the life sciences space, is a Senior Sales Executive and compliance and risk specialist at Xybion. He leads strategic engagements in manufacturing, quality and technology domains. Mr. Friel has been instrumental in guiding a number of key industry customers to a digital offering over the last 15 years, leveraging numerous technological advantages to vastly improve business operations and elevate customers as industry leaders.

 

Bob-Friedman-92x121

 

Bob Friedman
Chief Technologist
Xybion

Bob Friedman has more than 25 years of experience in Preclinical information systems at Xybion Corporation as a developer, development manager and Chief Solution Architect. He has been an active member of the CDISC SEND standards consortium for five years as well as the PhUSE / FDA Industry Collaboration. Bob has previously worked for Synthes Orthopedics, NYU Medical Center and the New York State Department of Health.